The Nifty Pharma index closed on a negative note on Thursday. Shares of Sun Pharmaceutical Industries Ltd.(up 2.11 per cent), ...

Kotak Institutional Equities suggests that high US tariffs on pharmaceuticals are unlikely. They maintain an optimistic ...

Avtozma, which is Celltrion’s twelfth biosimilar to be approved by the EC, is a recombinant humanised monoclonal antibody ...

Reuters Nifty continues to climb a wall of worry as it looks to be in the final leg of its rally before heading for a ...

Guidance for Total Revenues, Adjusted EBITDA and Adjusted EPS; Exceeds 2024 Guidance for Free Cash Flow [1] Reports 2024 ...

In a phase 2 trial, lusvertikimab significantly improves clinical and endoscopic outcomes in patients with moderate to severe ...

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it ...

If successful, Mankind’s drug would be the first oral small-molecule alternative, offering a pill-based treatment.

With that, I will now turn the call over to Sarah. Tsveta Milanova: Thanks, Sarah. By 2026, we have the potential to expand ...

MedImpact Healthcare Systems, the nation’s largest independent provider of health solutions, technology, and pharmacy benefit ...

Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical ...

The US FDA had conducted a current Good Manufacturing Practices inspection of Company's API manufacturing facility located at ...